ExpertiseUpdated on 4 January 2026
Offering Expertise of the group of Prof. Markus Scholz
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
About
Prof. Markus Scholz's team at the University of Leipzig specializes in developing advanced predictive models to address critical challenges in disease progression, treatment response, and personalized medicine. By leveraging cutting-edge statistical methods and machine learning techniques, the team creates robust models tailored to complex biological and clinical datasets.
Key aspects of their approach include:
· Advanced Parametrization: Employing sophisticated methods, such as regularization techniques, Bayesian frameworks, and neural networks, to enhance model accuracy and interpretability.
· Integration of External Data Sets: Enriching predictive power by combining internal data with external resources, including public databases, longitudinal studies, and multi-omics repositories.
· Machine Learning and AI: Harnessing techniques like deep learning, ensemble models, and transfer learning to discover complex patterns and improve predictions.
· Dynamic and Individualized Predictions: Developing personalized models for real-time disease monitoring and outcome forecasting, supporting precision healthcare.
The team's predictive modeling expertise is applied across various domains, including:
· Chronic and Infectious Diseases: Forecasting disease progression and identifying early warning signals.
· Therapeutic Outcomes: Predicting treatment efficacy and adverse effects to inform clinical decisions.
· Precision Medicine: Tailoring interventions based on patient-specific factors and molecular profiles.
With a strong focus on integrating diverse data types and applying state-of-the-art algorithms, Prof. Scholz’s team provides transformative insights that advance personalized medicine, support clinical decision-making, and improve health outcomes.
Field
- Screening & early detection programs (risk stratification, predictive tools)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Clinical decision support systems for personalised medicine
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Theranostics (combined diagnostic + therapeutic approaches)
Organisation
Similar opportunities
Expertise
Offering expertise of the group of Prof. Markus Scholz
- Clinical decision support systems for personalised medicine
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Partial adoption of a PM solution (testing selected modules/components)
- Screening & early detection programs (risk stratification, predictive tools)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the Group of Prof. Markus Scholz
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Screening & early detection programs (risk stratification, predictive tools)
- Data integration & interoperability solutions (EHRs, registries, data platforms)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the group of Prof. Markus Scholz
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Screening & early detection programs (risk stratification, predictive tools)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany